The company has already done a reverse split, it was many months ago, there was 125 million os they did a 5 to 1 reverse getting us back to 25 million os and a price share @ 2.00 dollars the stock was .40 @ the time, Nas wanted 1.00... after the split it could not hold... Fda was sitting on their hands to long for what they wanted... time ran out... back to bulletin board they have issued 25 some odd million shares to bring the os about 52 million now.
When they complete phase III and all fda requirements within the "phases" and the report is golden then the stock should be a strong one.
BUT
the new cfo has managed other companies by reversing their stock... it's the new stock structure I'm concerned about with this guy, if any of you get in the conference call, 'I can't have the time..' drill the hell out of them as to the structure of this if you like.
If all is managed well... this could be a mega huge one for this botanical type of hot flash drug and a super slingshot swing for the company.
Regards
